Document
false0000019617 0000019617 2020-03-05 2020-03-05 0000019617 jpm:DepositarySharesOneFourHundredthInterestinaShareof6.15NonCumulativePreferredStockSeriesBBMember 2020-03-05 2020-03-05 0000019617 jpm:DepositarySharesOneFourHundredthInterestinaShareof6.125NonCumulativePreferredStockSeriesYMember 2020-03-05 2020-03-05 0000019617 jpm:DepositarySharesOneFourHundredthInterestinaShareof6.00NonCumulativePreferredStockSeriesEEMember 2020-03-05 2020-03-05 0000019617 us-gaap:CommonStockMember 2020-03-05 2020-03-05 0000019617 jpm:GuaranteeofCallableSteUpFixedRateNotesDueApril262028ofJPMorganChaseFinancialCompanyLLCMember 2020-03-05 2020-03-05 0000019617 jpm:DepositarySharesOneFourHundredthInterestinaShareof6.10NonCumulativePreferredStockSeriesAAMember 2020-03-05 2020-03-05 0000019617 jpm:AlerianMLPIndexETNsDueMay242024Member 2020-03-05 2020-03-05 0000019617 jpm:DepositarySharesOneFourHundredthInterestinaShareof5.75NonCumulativePreferredStockSeriesDDMember 2020-03-05 2020-03-05 0000019617 jpm:DepositarySharesOneFourHundredthInterestinaShareof4.75NonCumulativePreferredStockSeriesGGMember 2020-03-05 2020-03-05


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): March 5, 2020
 
JPMorgan Chase & Co.
(Exact name of registrant as specified in its charter)
 
Delaware
1-5805
13-2624428
(State or other jurisdiction of
incorporation or organization)
(Commission File Number)
(I.R.S. employer
identification no.)
 
 
 
 
 
383 Madison Avenue,



New York,
New York
 
 
10179
(Address of principal executive offices)
 
 
(Zip Code)
Registrant’s telephone number, including area code: (212270-6000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common stock
JPM
The New York Stock Exchange
Depositary Shares, each representing a one-four hundredth interest in a share of 6.125% Non-Cumulative Preferred Stock, Series Y
JPM PR F
The New York Stock Exchange
Depositary Shares, each representing a one-four hundredth interest in a share of 6.10% Non-Cumulative Preferred Stock, Series AA
JPM PR G
The New York Stock Exchange
Depositary Shares, each representing a one-four hundredth interest in a share of 6.15% Non-Cumulative Preferred Stock, Series BB
JPM PR H
The New York Stock Exchange
Depositary Shares, each representing a one-four hundredth interest in a share of 5.75% Non-Cumulative Preferred Stock, Series DD
JPM PR D
The New York Stock Exchange
Depositary Shares, each representing a one-four hundredth interest in a share of 6.00% Non-Cumulative Preferred Stock, Series EE
JPM PR C
The New York Stock Exchange
Depositary Shares, each representing a one-four hundredth interest in a share of 4.75% Non-Cumulative Preferred Stock, Series GG
JPM PR J
The New York Stock Exchange
Alerian MLP Index ETNs due May 24, 2024
AMJ
NYSE Arca, Inc.
Guarantee of Callable Step-Up Fixed Rate Notes due April 26, 2028 of JPMorgan Chase Financial Company LLC
JPM/28
The New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

1



Item 8.01 Other Events
On March 5, 2020, Gordon Smith and Daniel Pinto, Co-Presidents and Co-Chief Operating Officers of JPMorgan Chase & Co. issued a letter to colleagues and shareholders informing them of a recent medical event about Jamie Dimon. A copy of the letter is attached as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits

(d)    Exhibit
 
 
 
Exhibit No.
 
Description of Exhibit
 
 
 
99.1
 
101
 
Pursuant to Rule 406 of Regulation S-T, the cover page is formatted in Inline XBRL (Inline eXtensible Business Reporting Language).
104
 
Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101).


2



SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
JPMorgan Chase & Co.
(Registrant)


By:
/s/ Molly Carpenter
 
Molly Carpenter
 
Corporate Secretary



Dated:
March 5, 2020



3
danielandgordondearcolle
Date: March 5, 2020  Subject line: Sharing important news about Jamie  Dear Colleagues, Shareholders and Clients ‐  We want to let you know that Jamie experienced an acute aortic dissection this morning.  He underwent  successful emergency heart surgery to repair the dissection.  The good news is that it was caught early  and the surgery was successful.  He is awake, alert and recovering well.    Our Lead Director, Lee Raymond, said today, “Our Board has been fully briefed on these developments  and has asked Daniel and Gordon to lead the company during this period, as Jamie recuperates. We  have exceptional leaders across our businesses and functions – led by our outstanding CEO and Co‐ Presidents.   Our company will move forward together with confidence as we continue to serve our  customers, clients, communities and shareholders.”   As Co‐Presidents and Chief Operating Officers, we have been working hand‐in‐hand with Jamie and the  Board over the past two years to help lead our company.  This is in addition to directly running the firm’s  Corporate & Investment Bank and Consumer & Community Banking businesses, which represent the  majority of the firm’s businesses.  We have also been deeply involved in all of the critical firmwide  functions.    Just last week, the firm hosted our Investor Day, where we provided comprehensive updates on our  strategy and priorities going forward.  We will continue to execute on all of these plans.   As we always have done, this is a time for all of us to stay focused on our important responsibilities.  We  know you all join us in wishing Jamie our very best and a smooth and speedy recovery.    Daniel & Gordon